Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$3.83 +0.20 (+5.51%)
At close: Oct 22, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Asset Writedowns and Impairment (2024)

Updated

Analysis

Verrica Pharmaceuticals (VRCA) Asset Writedowns and Impairment (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Verrica Pharmaceuticals 79.47 Mn -3.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -5,000.00
API Access

Verrica Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VRCA&period=max&api_key=YOUR_API_KEY